Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00419224 · ClinicalTrials.gov registry record · Phase 4
Influenza Vaccination in Bone Marrow Transplantation
A Phase 4 study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 36
- Enrollment target
NCT00419224 is a Phase 4 study that has completed, run by The Cleveland Clinic. The registered enrollment target is 36 participants.
The verdict
NCT00419224, a Phase 4 study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 36 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether influenza vaccination protects patients who receive a certain type of bone marrow transplantation.
Interventions
- BIOLOGICAL inactivated split-virus influenza vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2002-10 |
| Est. Completion | 2003-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00419224
The ClinicalTrials.gov registry entry for NCT00419224 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which inactivated split-virus influenza vaccine is the first listed.
NCT00419224 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00419224 about?
NCT00419224 is a clinical study titled "Influenza Vaccination in Bone Marrow Transplantation". The purpose of this study is to determine whether influenza vaccination protects patients who receive a certain type of bone marrow transplantation.
What is the current status of trial NCT00419224?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 36 participants. The study started on 2002-10. Estimated completion is 2003-04.
What interventions are being tested in trial NCT00419224?
The interventions under investigation include: inactivated split-virus influenza vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT00419224?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.